JERSEY CITY, N.J. , June 21, 2024 /PRNewswire/ -- InsightAce Analytic Pvt.
Ltd. announces the release of a market assessment report on the " Global Molecular Pharming Market Size, Share & Trends Analysis Report By Crop Source (Maize, Barley, Tobacco, Safflower, Rice, Alfalfa), By Technology ( Gene Gun , Agroinfiltration, Electroporation, Agrobacterium-Mediated Gene Transfer), By Application (Recombinant Antibodies, Hormones, Vaccines, Industrial Enzymes, Proteins & Protein-Based Materials, Technical Reagents, Nutritional Products), By End User (Biotechnology & Pharmaceutical Companies, Contract Manufacturing Organizations)- Market Outlook And Industry Analysis 2031" The Global Molecular Pharming Market is valued at US$ 457.7 Mn in 2023, and it is expected to reach US$ 1,399.
8 Mn by 2031, with a CAGR of 15.3% during the forecast period of 2024-2031. Download Free Sample and ToC of the Report: https://www.
insightaceanalytic.com/request-sample/1712 Molecular pharming refers to biologics production in plant systems to reduce the cost of microbial systems. Molecular farming is an innovative method for producing molecular medicines, including plasma proteins, enzymes, growth factors, vaccinations, and recombinant antibodies.
These medicines have widely accepted medicinal uses at a molecular level. The approach has the potential to change the pharmaceutical industry by providing highly efficient and cost-effective treatments to all segments of the population. Plant-based protein exp.
